Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-04 @ 1:14 PM
Study NCT ID:
NCT02761057
Status:
COMPLETED
Last Update Posted:
2025-01-13
First Post:
2016-05-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-02
First Submit QC Date:
None
Study First Post Date:
2016-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-06-06
Results First Submit QC Date:
None
Results First Post Date:
2022-09-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-21
Last Update Post Date:
2025-01-13
Last Update Post Date Type:
ACTUAL